Braskem S.A.
NYSE:BAKChemicals
-$0.40 today
- Market cap
- $343.37M
- Beta
- 0.67
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$11.45
Volume 3.32M
Average 2.97M
BAK Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Braskem S.A.NYSE: BAK
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures growth accelerates
Q1 FY2026 capital expenditures of R$661.39M (cash outflow) rose 1.3% year over year, ahead of the -10.8% change in trailing-twelve-month capital expenditures. Sequentially, it rose 13.5% from the prior quarter. Over 3 fiscal years it compounded at -14.1% a year.
Context
- Capital expenditures amounted to 4.4% of revenue in FY2025, down 0.4 pp from a year earlier.
- Capital expenditures grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +1.3% holds above the trailing-twelve-month pace of -10.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
BRL · from the cash flow
- Latest · FY2025
- (3.07B) BRL
- Year-over-year change
- +18.4%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (3.07B) | +18.4% |
| FY2024 | 2024-12-31 | (3.76B) | +17.0% |
| FY2023 | 2023-12-31 | (4.53B) | +6.6% |
| FY2022 | 2022-12-31 | (4.85B) | -41.7% |
| FY2021 | 2021-12-31 | (3.42B) | — |
Capital Expenditures vs competitors
How BAK compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -10.8% is the 7th highest of 10, against a peer median of +24.0%.
- Capital expenditures amounts to 4.7% of revenue for BAK, versus a peer median of 8.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$3.16B BRL | -10.8% | -14.1% | 4.7% | |
| LTM Mar 2026 | $177.13M USD | +356.6% | -25.9% | 7.6% | |
| LTM Mar 2026 | $100.49M USD | -11.0% | -5.7% | 7.0% | |
| LTM Apr 2026 | $73.18M USD | +37.1% | +63.8% | 11.2% | |
| LTM Mar 2026 | $68.42M USD | +24.0% | +13.4% | 5.5% | |
| LTM Mar 2026 | $60.28M USD | -20.5% | +6.1% | 7.4% | |
| LTM Mar 2026 | $57.98M USD | +49.2% | +4.4% | 9.0% | |
| LTM Mar 2026 | $44.66M USD | -15.9% | +22.7% | 18.9% | |
| LTM Mar 2026 | $13.43M USD | +7.6% | +29.2% | 49.9% | |
CNLCollective Mining Ltd. | LTM Mar 2026 | $11.23M USD | +4716.4% | +165.2% | — |
| LTM Mar 2026 | CA$0 CAD | — | — | — | |
| Peer median (excluding BAK) | — | +24.0% | +13.4% | 8.3% | |
Competitors are the stored peer set for BAK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 13.98B | 47M | (4.58B) | (17.73B) | (9.69B) |
| Depreciation & Amortization | 4.87B | 4.73B | 5.21B | 4.95B | 4.58B |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 14.39M | 0 | 10M | 0 | 0 |
| Change in Working Capital | (12.48B) | 3.97B | (3.96B) | 557M | (1.71B) |
| Accounts Receivables | (2.18B) | 4.65B | 72M | 609M | 321.56M |
| Inventory | (7.57B) | 2.14B | 1.81B | (181M) | 2.88B |
| Accounts Payables | 0 | 514M | 0 | 384M | (2.3B) |
| Other Working Capital | (2.73B) | (3.34B) | (5.84B) | (255M) | (2.61B) |
| Other Non-Cash Items | 8.39B | 203M | 1.05B | 14.66B | 2.72B |
| Operating Cash Flow | 14.79B | 8.95B | (2.27B) | 2.44B | (4.09B) |
| Capital Expenditures | (3.42B) | (4.85B) | (4.53B) | (3.76B) | (3.07B) |
| Acquisitions (Net) | 0 | (107M) | (78M) | 203M | 100M |
| Purchases of Investments | 0 | (64.97M) | 0 | 0 | (77.45M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 105.88M |
| Other Investing Activities | 40.65M | 72.97M | 83M | 73M | 0 |
| Investing Cash Flow | (3.38B) | (4.95B) | (4.53B) | (3.49B) | (2.94B) |
| Debt Repayment | (10.97B) | 1.55B | 8.28B | 437M | 3.2B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (5.99B) | (1.35B) | (7M) | (6M) | 0 |
| Other Financing Activities | 0 | 21M | 596M | 38M | (63.8M) |
| Financing Cash Flow | (16.97B) | 225M | 8.87B | 469M | 3.13B |
| Effect of Forex Changes | 377.53M | (444M) | (355M) | 1.38B | 1.1B |
| Net Change in Cash | (5.18B) | 3.79B | 1.72B | 799M | (2.79B) |
| Free Cash Flow | 11.37B | 4.1B | (6.8B) | (1.33B) | (7.16B) |
Braskem S.A.
NYSE:BAK
Intrinsic Alpha fair value
Locked
Current Price
$0.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.